Related references
Note: Only part of the references are listed.Postoperative C-reactive Protein Is a Predictive Biomarker for Survival After Non-small Cell Lung Cancer Resection
Shuichi Shinohara et al.
ANTICANCER RESEARCH (2019)
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers
Mingjia Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Current Diagnosis and Management of Small-Cell Lung Cancer
Shuhang Wang et al.
MAYO CLINIC PROCEEDINGS (2019)
High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs
Chao Deng et al.
MEDICINE (2019)
Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database
Shuang-Jiang Li et al.
INTERNATIONAL JOURNAL OF SURGERY (2019)
The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis
Ting Gong et al.
CELLULAR AND MOLECULAR BIOLOGY (2019)
Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer
Jia-Xin Liu et al.
FUTURE ONCOLOGY (2018)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma
Gyeong-Won Lee et al.
ACTA HAEMATOLOGICA (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors
Shiva Shrotriya et al.
PLOS ONE (2018)
The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review
Ross D. Dolan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer A meta-analysis
Junwu Duan et al.
MEDICINE (2018)
Pretreatment Controlling Nutritional Status Score and Lactate Dehydrogenase as Predictive Markers of Survival in Patients with Malignant Peritoneal Mesothelioma
Qing-Qing Wang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients
Hong Hu et al.
WORLD JOURNAL OF UROLOGY (2017)
The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy
Xiaofan Liu et al.
MEDICINE (2017)
Prognostic value of systemic immune-inflammation index in patients with gastric cancer
Kang Wang et al.
CHINESE JOURNAL OF CANCER (2017)
Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis
Xiuxiu Zhang et al.
CANCER BIOMARKERS (2016)
Small Cell Lung Cancer: Where Do We Go From Here?
Lauren Averett Byers et al.
CANCER (2015)
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
Beatrice Philip et al.
CARCINOGENESIS (2013)
Hyponatremia as prognostic factor in small cell lung cancer - A retrospective single institution analysis
Andreas Hermes et al.
RESPIRATORY MEDICINE (2012)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety and efficacy of darbepoetin alfa in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide
Robert Pirker et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up
S Sundstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
